Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2439Neoplasms 1845Carcinoma, Non-Small-Cell Lung 1615Prostatic Neoplasms 1315Colorectal Neoplasms 1149Lung Neoplasms 993Neoplasm Metastasis 838Multiple Myeloma 802Leukemia, Myeloid, Acute 778Ovarian Neoplasms 686Pancreatic Neoplasms 673Melanoma 669Squamous Cell Carcinoma of Head and Neck 592Carcinoma, Hepatocellular 571Recurrence 570Brain Neoplasms 531Glioblastoma 521Stomach Neoplasms 506Head and Neck Neoplasms 504Triple Negative Breast Neoplasms 474Lymphoma 463Uterine Cervical Neoplasms 457Carcinoma, Renal Cell 430Precursor Cell Lymphoblastic Leukemia-Lymphoma 421Lymphoma, Non-Hodgkin 392Endometrial Neoplasms 386Sarcoma 372Lymphoma, Follicular 358Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 356

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Fibroadenoma × 1 year × Clear all
NCT03044054 2026-05-01

HIFU-003

Theraclion

Phase NA Completed
113 enrolled

Fibroadenoma

NCT03868475 2026-03-09

VAPEX

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Withdrawn
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡